Inventor · disambiguated record
Julian Davies
Also filed as: DAVIES JULIAN · DAVIES JULIAN E
33 granted patents·8 pending applications·392 citations·filing 1980–2024
97Inventor score
Files withLILLY CO ELI10DAVIES JULIAN8ABCELLERA BIOLOGICS INC3PASTEUR INSTITUT3ABCELLERA BIOLOGIES INC2
Top patents by PatentIndex Score
41 records- 0196US8530414B2Antibodies to PCSK9 and uses thereofDAVIES JULIAN·Filed 2012·Granted Sep 10, 2013·58 cites·11 claims
- 0295US7632499B2Anti-myostatin antibodiesLILLY CO ELI·Filed 2006·Granted Dec 15, 2009·64 cites·10 claims
- 0395US7619069B2Antibodies to TGF-beta 1LILLY CO ELI·Filed 2007·Granted Nov 17, 2009·34 cites·13 claims
- 0494US8623365B2Aβ binding moleculesDAVIES JULIAN·Filed 2011·Granted Jan 7, 2014·13 cites·16 claims
- 0594US7354584B2Recombinant IL-9 antibodiesMEDIMMUNE INC·Filed 2004·Granted Apr 8, 2008·50 cites·9 claims
- 0692US11370828B2Anti-coronavirus antibodies and methods of useABCELLERA BIOLOGIES INC·Filed 2021·Granted Jun 28, 2022·9 cites·30 claims
- 0791US11447541B1Anti-coronavirus antibodies and methods of useABCELLERA BIOLOGIES INC·Filed 2021·Granted Sep 20, 2022·3 cites·26 claims
- 0888US8217148B2c-Met antibodiesDAVIES JULIAN·Filed 2009·Granted Jul 10, 2012·12 cites·19 claims
- 0987US8398974B2c-Met antibodiesDAVIES JULIAN·Filed 2012·Granted Mar 19, 2013·11 cites·20 claims
- 1087US7575747B2Aβ binding moleculesAPPLIED MOLECULAR EVOLUTION·Filed 2004·Granted Aug 18, 2009·10 cites·5 claims
- 1186US8066995B2Anti-myostatin antibodiesDAVIES JULIAN·Filed 2009·Granted Nov 29, 2011·11 cites·18 claims
- 1283US9201074B2Anti-c-Met antibodiesDAVIES JULIAN·Filed 2012·Granted Dec 1, 2015·4 cites·21 claims
- 1381US8105597B2Aβ binding moleculesDAVIES JULIAN·Filed 2009·Granted Jan 31, 2012·3 cites·7 claims
- 1479US9260531B2Anti-c-met antibodiesLILLY CO ELI·Filed 2013·Granted Feb 16, 2016·7 cites·24 claims
- 1578US8153125B2CD20 binding moleculesWATKINS JEFFRY D·Filed 2004·Granted Apr 10, 2012·20 cites·11 claims
- 1676US12172038B2Anti-coronavirus antibodies and methods of useABCELLERA BIOLOGICS INC·Filed 2023·Granted Dec 24, 2024·0 cites·25 claims
- 1775US6864056B1Method for detecting ribosome inactivating proteinsUS ARMY·Filed 2001·Granted Mar 8, 2005·4 cites·8 claims
- 1871US8481037B2Recombinant IL-9 antibodies and uses thereofREED JENNIFER LYNNE·Filed 2011·Granted Jul 9, 2013·2 cites·16 claims
- 1969US6455270B1Method for inhibiting eukaryotic protein kinasesTERRAGEN DISCOVERY INC·Filed 2000·Granted Sep 24, 2002·1 cites·5 claims
- 2067US5958687ANucleotide sequences and proteins conferring cycloheximide resistancePASTEUR INSTITUT·Filed 1997·Granted Sep 28, 1999·15 cites·18 claims
- 2166US10913793B2DNA molecules encoding anti-IL-33 antibodiesLILLY CO ELI·Filed 2019·Granted Feb 9, 2021·0 cites·5 claims
- 2265US8128927B2Methods of using TGF-β 1 binding compositionsDAVIES JULIAN·Filed 2009·Granted Mar 6, 2012·0 cites·8 claims
- 2364US5900406AUse of antibiotics of the type 2-deoxystreptamine substituted with aminosugars to inhibit growth of microorganisms containing group I intronsNZYM INC·Filed 1994·Granted May 4, 1999·35 cites·14 claims
- 2464US2022356229A1Anti-Coronavirus Antibodies and Methods of UseABCELLERA BIOLOGICS INC·Filed 2021·Application pending·0 cites
- 2563US2021292393A1Anti-Coronavirus Antibodies and Methods of UseABCELLERA BIOLOGICS INC·Filed 2020·Application pending·0 cites
- 2661US2024101670A1Anti-human lair1 antibodiesLILLY CO ELI·Filed 2023·Application pending·0 cites
- 2761US2009047277A1Recombinant il-9 antibodies and uses thereofMEDIMMUNE INC·Filed 2007·Application pending·0 cites
- 2860US2025205352A1COMPOSITIONS AND METHODS FOR MODULATING NaV1.8LILLY CO ELI·Filed 2024·Application pending·0 cites
- 2959US2013273071A1Recombinant IL-9 Antibodies And Uses ThereofMEDIMMUNE LLC·Filed 2013·Application pending·0 cites
- 3056US10501536B2Anti-IL-33 antibodies and uses thereof for disease treatmentLILLY CO ELI·Filed 2017·Granted Dec 10, 2019·0 cites·17 claims
- 3155US2025270309A1Antibodies and methods targeting interleukin-19LILLY CO ELI·Filed 2023·Application pending·0 cites
- 3253US2023167115A1Antiviral Agents, Uses Thereof and Methods for Their PreparationUNIV BRITISH COLUMBIA·Filed 2021·Application pending·0 cites
- 3348US6107068ACoenzyme A disulfide reductase, and inhibitors thereof useful as antimicrobial agentsUNIV BRITISH COLUMBIA·Filed 1997·Granted Aug 22, 2000·6 cites·24 claims
- 3447US6319898B1Method for inhibiting eukaryotic protein kinasesTERRAGEN DIVERSITY INC·Filed 1998·Granted Nov 20, 2001·10 cites·8 claims
- 3542US5770392AMethod and composition for identifying inhibitors of eukaryotic cell processesTERRAGEN DIVERSITY INC·Filed 1996·Granted Jun 23, 1998·7 cites·15 claims
- 3635US9394362B2IL-21 antibodies and methods of making or using the antibodiesLILLY CO ELI·Filed 2015·Granted Jul 19, 2016·0 cites·27 claims
- 3734US6132984AMethod for inhibiting eukaryotic protein kinasesTERRAGEN DISCOVERY INC·Filed 1998·Granted Oct 17, 2000·2 cites·3 claims
- 3830US11267882B2Methods of detecting human IL-21LILLY CO ELI·Filed 2017·Granted Mar 8, 2022·0 cites·10 claims
- 3930US5830997ANucleotide sequences and proteins conferring cycloheximide resistancePASTEUR INSTITUT·Filed 1997·Granted Nov 3, 1998·0 cites·5 claims
- 4027US5641674ANucleotide sequences and proteins conferring cycloheximide resistancePASTEUR INSTITUT·Filed 1992·Granted Jun 24, 1997·0 cites·24 claims
- 4127US4330621AAssay for aminoglycosidesWISCONSIN ALUMNI RES FOUND·Filed 1980·Granted May 18, 1982·1 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Julian Davies files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →